CN Patent

CN106176752B — 色瑞替尼药物组合物

Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2020-06-23 · 6y expired

What this patent protects

本发明涉及一种色瑞替尼药物组合物，该药物组合物含有色瑞替尼和至少一种药学上可接受的载体，原料粒径D90在20μm～80μm范围内，该药物组合物释放迅速，质量稳定；本发明还涉及所述药物组合物的制备方法，该制备方法制备工艺简单，适合工业化大生产。

USPTO Abstract

本发明涉及一种色瑞替尼药物组合物，该药物组合物含有色瑞替尼和至少一种药学上可接受的载体，原料粒径D90在20μm～80μm范围内，该药物组合物释放迅速，质量稳定；本发明还涉及所述药物组合物的制备方法，该制备方法制备工艺简单，适合工业化大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN106176752B
Jurisdiction
CN
Classification
—
Expires
2020-06-23
Drug substance claim
No
Drug product claim
No
Assignee
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.